Work

The selective type A endothelin antagonist atrasentan reduces residual albuminuria in patients with type 2 diabetes and nephropathy

Year: 2013

Type: article

Source: Life Sciences

DOI: 10.1016/j.lfs.2013.12.226

Authors: Dennis L. Andress, Dick de Zeeuw, Hans-Henrik Parving

Institutions: AbbVie (United States), University of Groningen, Copenhagen University Hospital

Language: English

Topic: Chronic Kidney Disease and Diabetes

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,810

OpenAlex ID: W2051145864

FWCI: 0.227

Cites:

Cited by: 1

Related to: 10